Tricuspid atresia medical therapy: Difference between revisions
Jump to navigation
Jump to search
| Line 7: | Line 7: | ||
*The mainstay of therapy for the cyanotic neonate with severe | *The mainstay of therapy for the cyanotic neonate with severe[[ pulmonary stenosis]] and small sized [[VSD]] is using[[ prostaglandin E1]] (PGE1) for keeping patency of [[ductus arteriosis]]. | ||
*The mainstay of therapy for heart failure symptoms is using diuretic for | *The mainstay of therapy for [[heart failure]] symptoms is using [[diuretic]] for reduction of [[congestion ]]and then starting [[ ACEI]]. | ||
Surgery | Surgery | ||
Surgery is the mainstay of therapy for tricuspid atresia. | Surgery is the mainstay of therapy for tricuspid atresia. | ||
In the first 8 weeks of life if there is severe [[cyanosis]] and [[pulmonary obstruction]] and normal positioning [[aorta]] and [[pulmonary artery]], making a shunt between systemic [[subclavian artery]] to the[[ pulmonary artery]] is necessary which is called [[Blalock -Taussig]](BT shunt). | |||
If the [[pulmonary artery]] comes from the [[left ventricle]] and is [[overflowed]], [[pulmonary artery]] banding is useful for lowering the [[pulmonary blood flow]]. | |||
In older children, bi-direction [[Glenn shunt]] which is the connection between [[superior vena cava ]]to the[[ pulmonary artery]] will be done for transferring the blood to the [[pulmonary system]]. | |||
Fontan procedure is a conduit between the inferior vena cava and the pulmonary artery and transfers the systemic venous blood to pulmonary circulation in the age of 2-3 years old. | Fontan procedure is a conduit between the inferior vena cava and the pulmonary artery and transfers the systemic venous blood to pulmonary circulation in the age of 2-3 years old. | ||
Endocarditis prophylaxis before every procedure is recommended. | Endocarditis prophylaxis before every procedure is recommended. | ||
Revision as of 16:11, 24 August 2020
|
Tricuspid atresia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Special Scenarios |
|
Case Studies |
|
Tricuspid atresia medical therapy On the Web |
|
American Roentgen Ray Society Images of Tricuspid atresia medical therapy |
|
Risk calculators and risk factors for Tricuspid atresia medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Keri Shafer, M.D. [2] Priyamvada Singh, MBBS [3]; Assistant Editor-In-Chief: Kristin Feeney, B.S. [4]
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Medical Therapy
- The mainstay of therapy for the cyanotic neonate with severepulmonary stenosis and small sized VSD is usingprostaglandin E1 (PGE1) for keeping patency of ductus arteriosis.
- The mainstay of therapy for heart failure symptoms is using diuretic for reduction of congestion and then starting ACEI.
Surgery Surgery is the mainstay of therapy for tricuspid atresia.
In the first 8 weeks of life if there is severe cyanosis and pulmonary obstruction and normal positioning aorta and pulmonary artery, making a shunt between systemic subclavian artery to thepulmonary artery is necessary which is called Blalock -Taussig(BT shunt). If the pulmonary artery comes from the left ventricle and is overflowed, pulmonary artery banding is useful for lowering the pulmonary blood flow. In older children, bi-direction Glenn shunt which is the connection between superior vena cava to thepulmonary artery will be done for transferring the blood to the pulmonary system.
Fontan procedure is a conduit between the inferior vena cava and the pulmonary artery and transfers the systemic venous blood to pulmonary circulation in the age of 2-3 years old. Endocarditis prophylaxis before every procedure is recommended.